Topotarget announces the final results from the first stage of the phase II part of the phase I/II clinical trial of belinostat in combination with doxorubicin in patients with soft tissue sarcomas (STS) (PXD101-CLN-14).
Help employers find you! Check out all the jobs and post your resume.
